These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 34054808)

  • 1. Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles.
    Hsieh MH; Beirag N; Murugaiah V; Chou YC; Kuo WS; Kao HF; Madan T; Kishore U; Wang JY
    Front Immunol; 2021; 12():641360. PubMed ID: 34054808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation.
    Beirag N; Kumar C; Madan T; Shamji MH; Bulla R; Mitchell D; Murugaiah V; Neto MM; Temperton N; Idicula-Thomas S; Varghese PM; Kishore U
    Front Immunol; 2022; 13():960733. PubMed ID: 35967323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples.
    Madan T; Biswas B; Varghese PM; Subedi R; Pandit H; Idicula-Thomas S; Kundu I; Rooge S; Agarwal R; Tripathi DM; Kaur S; Gupta E; Gupta SK; Kishore U
    Am J Respir Cell Mol Biol; 2021 Jul; 65(1):41-53. PubMed ID: 33784482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein D.
    Al-Ahdal MN; Murugaiah V; Varghese PM; Abozaid SM; Saba I; Al-Qahtani AA; Pathan AA; Kouser L; Nal B; Kishore U
    Front Immunol; 2018; 9():1586. PubMed ID: 30105014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms.
    Xu C; Wang A; Geng K; Honnen W; Wang X; Bruiners N; Singh S; Ferrara F; D'Angelo S; Bradbury ARM; Gennaro ML; Liu D; Pinter A; Chang TL
    Viruses; 2021 May; 13(6):. PubMed ID: 34064066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2.
    Arroyo R; Grant SN; Colombo M; Salvioni L; Corsi F; Truffi M; Ottolina D; Hurst B; Salzberg M; Prosperi D; Kingma PS
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
    Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity.
    Al-Qahtani AA; Murugaiah V; Bashir HA; Pathan AA; Abozaid SM; Makarov E; Nal-Rogier B; Kishore U; Al-Ahdal MN
    Immunobiology; 2019 May; 224(3):408-418. PubMed ID: 30954271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.
    Rahman M; Irmler M; Keshavan S; Introna M; Beckers J; Palmberg L; Johanson G; Ganguly K; Upadhyay S
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis.
    Hou Y; Ge S; Li X; Wang C; He H; He L
    Chem Biol Interact; 2021 Apr; 338():109420. PubMed ID: 33609497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2.
    Tada T; Fan C; Chen JS; Kaur R; Stapleford KA; Gristick H; Dcosta BM; Wilen CB; Nimigean CM; Landau NR
    Cell Rep; 2020 Dec; 33(12):108528. PubMed ID: 33326798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2.
    Edwards MJ; Becker KA; Gripp B; Hoffmann M; Keitsch S; Wilker B; Soddemann M; Gulbins A; Carpinteiro E; Patel SH; Wilson GC; Pöhlmann S; Walter S; Fassbender K; Ahmad SA; Carpinteiro A; Gulbins E
    J Biol Chem; 2020 Nov; 295(45):15174-15182. PubMed ID: 32917722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication.
    Artman C; Brumfield KD; Khanna S; Goepp J
    PLoS One; 2021; 16(5):e0252399. PubMed ID: 34048457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions.
    Goc A; Sumera W; Rath M; Niedzwiecki A
    PLoS One; 2021; 16(6):e0253489. PubMed ID: 34138966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human surfactant protein A inhibits SARS-CoV-2 infectivity and alleviates lung injury in a mouse infection model.
    Jacob IB; Gemmiti A; Xiong W; Reynolds E; Nicholas B; Thangamani S; Jia H; Wang G
    Front Immunol; 2024; 15():1370511. PubMed ID: 38596675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
    Choudhury A; Mukherjee S
    J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis.
    Bayati A; Kumar R; Francis V; McPherson PS
    J Biol Chem; 2021; 296():100306. PubMed ID: 33476648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glyceraldehyde-3-Phosphate Dehydrogenase Binds with Spike Protein and Inhibits the Entry of SARS-CoV-2 into Host Cells.
    Dilawari R; Chaubey GK; Modanwal R; Dhiman A; Talukdar S; Kumar A; Raje CI; Raje M
    J Innate Immun; 2024; 16(1):133-142. PubMed ID: 38325356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry.
    Shirato K; Kanou K; Kawase M; Matsuyama S
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27733646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.